FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?
作者信息
Zijlstra Josée M, Burggraaff Coreline N, Kersten Marie José, Barrington Sally F
机构信息
Department of Hematology, VU University medical center, Amsterdam, the Netherlands
Department of Hematology, VU University medical center, Amsterdam, the Netherlands.
出版信息
Haematologica. 2016 Nov;101(11):1279-1283. doi: 10.3324/haematol.2016.142752.
Abstract
摘要
相似文献
1
FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）作为弥漫性大B细胞淋巴瘤以及霍奇金淋巴瘤早期反应的生物标志物？是否已准备好在临床实践中应用？
Haematologica. 2016 Nov;101(11):1279-1283. doi: 10.3324/haematol.2016.142752.
2
Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma.淋巴瘤中骨髓活检及骨髓氟代脱氧葡萄糖正电子发射断层扫描的机遇与局限
Blood Rev. 2015 Nov;29(6):417-25. doi: 10.1016/j.blre.2015.06.003. Epub 2015 Jun 17.
3
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.弥漫性大 B 细胞淋巴瘤和霍奇金淋巴瘤患者中氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）中期再分期作用的更新。
J Natl Compr Canc Netw. 2010 Mar;8(3):347-52. doi: 10.6004/jnccn.2010.0023.
4
Role of PET in lymphoma.正电子发射断层扫描（PET）在淋巴瘤中的作用。
Curr Treat Options Oncol. 2014 Jun;15(2):248-61. doi: 10.1007/s11864-014-0278-4.
5
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes.目前关于氟-18 氟代脱氧葡萄糖正电子发射断层扫描在预测晚期霍奇金淋巴瘤和弥漫性大 B 细胞淋巴瘤治疗结局中的临床证据。
Leuk Lymphoma. 2009 Nov;50(11):1750-2. doi: 10.3109/10428190903308080.
6
An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma.基于证据的综述：氟脱氧葡萄糖正电子发射断层扫描在评估淋巴瘤治疗反应中的价值。
Semin Oncol. 2017 Dec;44(6):404-419. doi: 10.1053/j.seminoncol.2018.01.005. Epub 2018 Apr 22.
7
FDG-PET scan and treatment planning for early stage Hodgkin lymphoma.
Radiother Oncol. 2007 Nov;85(2):176-7. doi: 10.1016/j.radonc.2007.08.009. Epub 2007 Oct 24.
8
FDG-PET imaging in cutaneous anaplastic large cell lymphoma.
Clin Nucl Med. 2006 Sep;31(9):564-5. doi: 10.1097/01.rlu.0000233225.67721.ea.
9
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.氟-18-氟脱氧葡萄糖正电子发射断层扫描用于晚期霍奇金淋巴瘤和弥漫性大B细胞淋巴瘤的中期疗效评估：一项系统评价
J Clin Oncol. 2009 Apr 10;27(11):1906-14. doi: 10.1200/JCO.2008.16.0861. Epub 2009 Mar 9.
10
FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease.治疗1个周期后的氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）可预测弥漫性大细胞淋巴瘤和经典型霍奇金淋巴瘤的预后。
Cancer. 2006 Dec 1;107(11):2678-87. doi: 10.1002/cncr.22276.
引用本文的文献
1
Quantitative PET-based biomarkers in lymphoma: getting ready for primetime.基于定量 PET 的淋巴瘤生物标志物：准备迎接黄金时代。
Nat Rev Clin Oncol. 2023 Sep;20(9):640-657. doi: 10.1038/s41571-023-00799-2. Epub 2023 Jul 17.
2
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options.弥漫性大B细胞淋巴瘤（DLBCL）：患者早期管理及新出现的治疗选择
Onco Targets Ther. 2022 Dec 6;15:1481-1501. doi: 10.2147/OTT.S326632. eCollection 2022.
3
2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management.2021 年弥漫性大 B 细胞淋巴瘤更新：当前数据的综述及风险分层和管理方面的潜在应用。
Am J Hematol. 2021 May 1;96(5):617-629. doi: 10.1002/ajh.26151. Epub 2021 Mar 19.
4
Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.定义弥漫性大 B 细胞淋巴瘤基线代谢肿瘤体积的最佳测量方法。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1142-1154. doi: 10.1007/s00259-018-3953-z. Epub 2018 Feb 19.
5
Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability.PET/MR 上肝脏 18F-FDG 摄取测量：感兴趣区位置对可重复性的影响。
Contrast Media Mol Imaging. 2017 May 30;2017:8639731. doi: 10.1155/2017/8639731. eCollection 2017.
6
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.用于霍奇金淋巴瘤和非霍奇金淋巴瘤治疗监测的氟代脱氧葡萄糖正电子发射断层显像（FDG PET）
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):97-110. doi: 10.1007/s00259-017-3690-8. Epub 2017 Apr 14.
本文引用的文献
1
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.基于中期PET-CT扫描指导的晚期霍奇金淋巴瘤适应性治疗
N Engl J Med. 2016 Jun 23;374(25):2419-29. doi: 10.1056/NEJMoa1510093.
2
PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.正电子发射断层扫描在弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤分期及再分期中的应用
Curr Hematol Malig Rep. 2016 Jun;11(3):185-95. doi: 10.1007/s11899-016-0318-1.
3
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.美国采用早期中期氟脱氧葡萄糖-正电子发射断层扫描成像对Ⅲ至Ⅳ期霍奇金淋巴瘤进行适应性治疗的多中心试验：西南肿瘤协作组S0816。
J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11.
4
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL.基线代谢肿瘤体积与PET/CT早期反应相结合可改善弥漫性大B细胞淋巴瘤无进展生存期的预测。
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1209-19. doi: 10.1007/s00259-016-3315-7. Epub 2016 Feb 23.
5
PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study.PET-CT 用于分期和早期反应：来自晚期霍奇金淋巴瘤适应性治疗研究的结果。
Blood. 2016 Mar 24;127(12):1531-8. doi: 10.1182/blood-2015-11-679407. Epub 2016 Jan 8.
6
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.早期霍奇金淋巴瘤的 PET 导向治疗试验结果。
N Engl J Med. 2015 Apr 23;372(17):1598-607. doi: 10.1056/NEJMoa1408648.
7
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).基于早期[18F]氟代脱氧葡萄糖正电子发射断层扫描的侵袭性非霍奇金淋巴瘤适应性治疗：东部肿瘤协作组-美国放射肿瘤学会癌症研究组研究（E3404）
Br J Haematol. 2015 Jul;170(1):56-65. doi: 10.1111/bjh.13389. Epub 2015 Mar 30.
8
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.Ⅱ期研究：PET-CT 引导下的中期疗效评估，调整治疗方案，用于治疗晚期霍奇金淋巴瘤。
Ann Oncol. 2015 Jun;26(6):1170-1174. doi: 10.1093/annonc/mdv077. Epub 2015 Feb 20.
9
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描：欧洲核医学与分子影像学会肿瘤显像程序指南：第2.0版。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
10
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.影像学在淋巴瘤分期及疗效评估中的作用：恶性淋巴瘤国际会议影像工作组共识
J Clin Oncol. 2014 Sep 20;32(27):3048-58. doi: 10.1200/JCO.2013.53.5229.
Zotero 插件